Additionally, novel 1,8-Naphthalimide derivatives have been demonstrated to induce DNA damage and autophagic cell death in lung cancer cells through the inhibition of the human demethylase fat mass and obesity-associated protein (FTO), resulting in suppressed multicellular spheroid growth of lung cancer cells [28]. Here, FTO is linked to lung cancer.